Showing results (91-100 of 258) with videos related to
Sort By:
Pageof 26
Pharmacoeconomics|August 6, 1993
Drug expenditure and new drug introductions: the Swedish experienceU G Gerdtham, M Johannesson, B JönssonLaeknabladid|August 12, 2009
[Elective splenectomies in Landspítalinn 1985-1994.]S Gunnlaugsson, G M Johannesson, J MagnussonPharmacoeconomics|April 8, 1992
Economic evaluation of drug therapy: a review of the contingent valuation methodM Johannesson, P O Johansson, B JönssonHealth Economics|November 1, 1996
Valuation of health changes with the contingent valuation method: a test of scope and question order effectsB Kartman, N O Stålhammar, M JohannessonJournal of Health Economics|September 4, 1998
Time spent on waiting lists for medical care: an insurance approachM Johannesson, P O Johansson, T SöderqvistArchives of Internal Medicine|September 26, 1994
Is misoprostol cost-effective in the prevention of nonsteroidal anti-inflammatory drug-induced gastropathy in patients with chronic arthritis? A review of conflicting economic evaluationsG Stucki, M Johannesson, M H LiangMedical Decision Making : an International Journal of the Society for Medical Decision Making|October 31, 1997
Incorporating future costs in medical cost-effectiveness analysis: implications for the cost-effectiveness of the treatment of hypertensionM Johannesson, D Meltzer, R M O'ConorJournal of Dental Research|November 1, 1987
Cost-effectiveness analysis of periodontal disease controlA A Antczak-Bouckoms, M C WeinsteinHealth Policy (Amsterdam, Netherlands)|June 8, 1991
The costs of treating hypertension--an analysis of different cut-off pointsM Johannesson, L Borgquist, B Jönsson, et al.Journal of Health Economics|May 29, 1999
A note on validating Wagstaff and van Doorslaer's health measure in the analysis of inequalities in healthU G Gerdtham, M Johannesson, L Lundberg, et al.Pageof 26